WITHDRAWAL OF FORM S-3 OF TRINITY BIOTECH PLC
IDA Business Park
Bray, Co. Wicklow
Ireland
011 353 1 276 9800
1933 Act Rule 477
1933 Act File No. 333-107330
July 25, 2003
VIA EDGAR
---------
U.S. Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Subject: Withdrawal of Registration Statement on Form S-3 of
Trinity Biotech PLC; Accession No. 0001089355-03-000342;
File No. 333-107330
--------------------------------------------------------
Ladies and Gentlemen:
In accordance with Rule 477 promulgated under the Securities Act of 1933,
as amended, Trinity Biotech plc (the "Registrant") hereby respectfully requests
that the U.S. Securities and Exchange Commission (the "Commission") consent to
the withdrawal of its Registration Statement on Form S-3, as filed with the
Commission via EDGAR on July 25, 2003, at 13:21 (Registration No. 333-107330;
Accession No. 0001089355-03-000342) (the "Registration Statement").
The Registration Statement relates to the resale of shares by the selling
shareholders named in the Registration Statement. This request is being made
after consultation with the Commission Staff regarding the need to file a
Registration Statement on Form F-3 for the resale of shares of foreign private
issuers.
The Registration Statement is not yet effective; therefore, no securities
were sold in connection with the offering. It is our opinion the withdrawal of
this Registration Statement would be consistent with the public interest and the
protection of investors.
Accordingly, we request that an order granting the withdrawal of this
Registration Statement be deemed granted by the Commission immediately.
We appreciate your prompt attention to this matter. If you have any
questions regarding the foregoing application for withdrawal, please contact
Peter Flagel, Esq. of Carter Ledyard & Milburn LLP at (212) 238-8649.
Very truly yours,
/s/ Rory Nealon
--------------------------
Rory Nealon
Chief Financial Officer and Secretary